NCT00256295View on ClinicalTrials.gov

Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

October 31, 2011

Conditions
Cancer of the Head and Neck
Interventions
DRUG

Gemcitabine

1000 mg/m2 IV over 100 minutes Every 21 days

DRUG

Oxaliplatin

65 mg/m2 IV over 120 minutes immediately following gemcitabine Every 21 days

Trial Locations (1)

92868

Chao Family Comprehensive Cancer Center, Orange

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Sai-Hong Ignatius Ou

OTHER